ppPLUS: Technologies and more


Go to Homepage to browse companies and process data

ppPLUS-Solutions providing Services and Support

Register creating your own models

Name
Invista ADN Technology
Owner
/ Invista Equities, LLC
Brand
Process
Hydrocyanation
Type
Hydrocyanation of 1,3-Butadiene into Adiponitrile
Available

Technology History

The direct hydrocyanation of butadiene to adiponitrile (ADN) was pioneered by William C. Drinkard at DuPont in 1967, representing a breakthrough in homogeneous catalysis that revolutionized ADN production[1][2]. This technology replaced earlier multi-step chlorocyanation routes and became commercially operational in 1971 at DuPont's Orange, Texas facility, marking the 50th anniversary of commercial ADN production in 2021[3].

The process evolved from initial monodentate phosphite ligand systems to advanced bidentate phosphite ligand catalysts that offer superior performance in terms of selectivity, turnover rates, and catalyst stability[4]. In 2012, INVISTA unveiled a transformative butadiene-based "new ADN technology" that achieved improved product yields, reduced energy consumption, lower CO2 emissions, as well as virtually eliminating benzene from the production process[5].

Technology Summary and Recent Technological Improvements

Core Process Chemistry

The INVISTA process employs a three-step hydrocyanation sequence (Fig. 1)[6][7][8][9]:

  1. Primary Hydrocyanation: 1,3-butadiene + hydrogen cyanaide (HCN) → mixture of 3-pentenenitrile (3PN) and 2-methyl-3-butenenitrile (2M3BN)
  2. Isomerization: 2M3BN → 3PN (to maximize linear nitrile formation)
  3. Secondary Hydrocyanation: 3PN + HCN → adiponitrile (+ minor 2-methylglutaronitrile)

Figure 1 - Hydrocyanation of 1,3-butadiene to adiponitrile[7]
 

Recent Technological Improvements (2014 onwards)

Based on INVISTA's patent portfolio and commercial deployments[5][9][10][11][12]:

  • Benzene Elimination: Complete elimination of benzene formation as a by-product
  • Enhanced Process Stability: More consistent operation and reliability
  • Improved Yields: Higher conversion efficiency and product selectivity
  • Reduced Energy Consumption: Better heat integration and process optimization
  • Lower Greenhouse Gas Emissions: Environmental performance improvements
  • Reduced Capital Intensity: Lower infrastructure requirements for new installations

Detailed Step-by-Step Technology Description

Process Flow Based on Patent Analysis

Figure 2 - Hydrocyanation of 1,3-butadiene to adiponitrile block flow diagram reconstructed based on patents US9040735B2[13], US10035756B2[14], EP1344770A1[15], and related INVISTA filings

Step 1: Primary Hydrocyanation Reactor

Patent Basis: EP1344770A1[15], US20080015378A1[16]

  • Reactants: 1,3-butadiene (<5 ppm 4-tert-butylcatechol) + HCN
  • Catalyst System
    • Zero-valent nickel [Ni(COD)₂ preferred]
    • Bidentate phosphite ligands with specific structural formulae
    • Molar ratio butadiene:catalyst = 10:1 to 100,000:1 (preferred 100:1 to 5,000:1)
    • Molar ratio HCN:catalyst = 10:1 to 100,000:1 (preferred 100:1 to 5,000:1)
  • Conditions:
    • Temperature: 25-200°C (preferred 50-150°C)
    • Pressure: 5 kPa to 10,000 kPa (preferred 500-2000 kPa)
    • Reaction time: 2 seconds to 24 hours
  • Products: ~65% 3PN, ~35% 2M3BN mixture

Step 2: Isomerization Reactor

Patent Basis: US9040735B2[13], research insights

  • Feed: 2M3BN from primary hydrocyanation
  • Catalyst: Same nickel-phosphite complex + Lewis acid co-catalyst
  • Lewis Acid: ZnCl₂, AlCl₃, or other Lewis acids
  • Conditions:
    • Temperature: 60-120°C (typical 80-120°C)
    • Pressure: 1-10 bar
  • Mechanism: Reversible C-CN bond activation via σ-alkyl and π-allyl intermediates
  • Performance: Single-pass conversion 26.4%, selectivity to 3PN: 79.8%

Step 3: Secondary Hydrocyanation Reactor

Patent Basis: US20120035387A1[17], US9040735B2[13]

  • Feed: 3PN + 4PN from Step 1 and Step 2 + HCN
  • Catalyst: Ni-phosphite complex + Lewis acid promoter (preferably ZnCl₂ or AlCl₃)
  • Enhanced Water Control (US9040735B2): Water concentration maintained at 100-400 ppm to prevent ligand degradation
  • Conditions
    • Temperature: 25-80°C (typical 30-130°C)
    • Pressure: 1-20 bar
    • Residence time: 5-40 hours (typical 15-30 hours)
  • HCN conversion: >99%

Step 4: Catalyst Recovery and Product Purification

Patent Basis: US10035756B2[14]

  • Liquid-Liquid Extraction: Enhanced with Lewis base additives (water, ammonia, polyamines)
  • Lewis Base Enhancement: Addition of bis-hexamethylenediamine (BHMT) or hexamethylenediamine (HMD) improves catalyst recovery efficiency
  • Multi-stage Countercurrent Extraction: Cyclohexane as extraction solvent
  • Distillation Train: Four-column system for ADN purification

Process Conditions and Parameters Summary

Process Step Temperature (°C) Pressure (bar) Key Parameters
Primary HCN 50-150 5-20 Butadiene:HCN:Cat
 1000:1000:1
Isomerization 80-120 1-10 Ni:Lewis Acid = 1:1,
residence time variable
Secondary HCN 30-130 1-20 HCN:Cat = 500-1000:1,
water 100-400 ppm
Extraction 40-80 ~1 Cyclohexane solvent,
polyamine additives

 

Technology Performance

Yields and Selectivity

Based on patent examples and literature data[6][9]:

  • Overall ADN Yield: 97-99% of theoretical
  • Primary HCN Selectivity: 3PN ~65%, 2M3BN ~35%
  • Isomerization Efficiency: 79.8% selectivity to 3PN
  • Secondary HCN Selectivity: 81-90% to ADN (depends on Lewis acid)
  • Product Purity: >99.5% ADN after distillation

Energy Efficiency

Recent INVISTA improvements[16]:

  • Reduced energy consumption through advanced heat integration
  • Enhanced process stability reducing energy losses
  • Optimized catalyst recovery reducing regeneration energy

Economic Performance

While specific cost breakdowns remain proprietary, the process economics are driven by:

  • Raw Material Efficiency: >97% conversion of butadiene and HCN[13][15][18]
  • Catalyst Costs: Significant but offset by high recycling efficiency and long catalyst life[13][14][19]
  • Energy Costs: Reduced through process intensification[10][11][12]
  • Capital Efficiency: Improved through INVISTA's latest technology reducing capital intensity[10][11][12][18]

Commercial Experience

Global Deployment Timeline

  • 1971: First commercial plant (Orange, Texas)[3]
  • 2014: "New ADN technology" deployed at Orange, Texas[20]
  • 2017: Technology retrofit at Butachimie JV (France)[10][12]
  • 2021: Installation at Victoria, Texas ($250M investment)[21]
  • 2022: Deployment at Shanghai, China (400,000 t/y capacity)[21]
  • 2024: ADN production at Orange, Texas, shut down[23] 

Market Position

  • INVISTA: Dominant technology licensor with >90% of global ADN capacity using hydrocyanation
  • Major Producers: INVISTA, Butachimie (INVISTA/Solvay JV), BASF SE
  • Technology Licensing: INVISTA and Butachimie are primary licensors for new plants
  • Competitive Advantage: Proprietary catalyst formulations and process optimization provide sustained market leadership[18]

Proprietary Technology Elements

Based on the patent analysis, INVISTA's competitive advantages include[13][14][15][16][17]:

  1. Catalyst Systems: Proprietary bidentate phosphite ligand formulations
  2. Process Integration: Advanced heat integration and separation technologies
  3. Lewis Acid Optimization: Specific promoter combinations for enhanced selectivity
  4. Water Management: Critical water concentration control for catalyst stability
  5. Extraction Enhancement: Polyamine additives for improved catalyst recovery
  6. Benzene-Free Innovation: undisclosed process modifications virtually eliminating benzene formation

References

  1. William C. Drinkard - Wikipedia
  2. William C Drinkard, Richard V Lindsey Jr, Hydrocyanation of olefins using selected nickel phosphite catalysts, United States Patent US3496215A, Patent Filed: Nov 11, 1965, EI Du Pont de Nemours and Co
  3. Nov 1987 - Health and Environmental Effects Document for Adiponitrile - U.S. Environmental Protection Agency (EPA)
  4. Ronald James Mckinney, Process for the hydrocyanation of butadiene, European Patent EP1344770A1, Invista Technologies Saerl
  5. PlasticsToday Staff, May 18, 2012 - Invista unveils new production technology for key nylon intermediate - PLASTICS TODAY
  6. Xuan Luo et al., Production technology of adiponitrile, E3S Web of Conferences,Vol. 441, Article Nr. 01019, (2023), DOI: 10.1051/e3sconf/202344101019
  7. Kaikai Liu, Research on Catalysts for the Hydrocyanation of 1,3-Butadiene to Adiponitrile, 2020 Virtual AIChE Annual Meeting, ISBN 978-0-8169-1114-1
  8. Liu, Kaikai, Shuai Zhang, and Minghan Han. 2020. Mechanistic Investigation on Hydrocyanation of Butadiene: A DFT StudyCatalysts 10, no. 8: 818. DOI: 10.3390/catal10080818
  9. Laura Bini. (2009). Mechanistic insights into the hydrocyanation reaction. [Phd Thesis 1 (Research TU/e / Graduation TU/e), Chemical Engineering and Chemistry]. Technische Universiteit Eindhoven. DOI: 10.6100/IR644067
  10. Sep 27, 2017 - Invista to Install New ADN Technology in France - CHEManager
  11. TORZEN® Nylon 6,6 Engineering Polymers Brochure - STUDYLIB
  12. Mary Bailey, Sep 21, 2017 - Invista to install new adiponitrile process technology at Butachimie site in France - Chemical Engineering
  13. Aki Sudhir et al., Process for making nitriles, United States Patent US9040735B2, Patent filed: Oct 4, 2012, Invista North America S.a.r.l.
  14. William J. Tenn, Integrated process for nitrile manufacture with enhanced liquid-liquid extraction, United States Patent US10035756B2, Patent filed: Jun 25, 2015, Invista North America S.a.r.l.
  15. Ronald James McKinney, Process for the hydrocyanation of butadiene, European Patent EP1344770A1, Patent filed: Mar 10, 2003, E.I. du Pont de Nemours and Company
  16. Thomas Foo et al., Process for making 3-pentenenitrile by hydrocyanation of butadiene, United States Patent US20080015378A1, Patent filed: Jul 12, 2007, Invista North America LLC
  17. James Michael Gartner et al., Hydrocyanation of 2-pentenenitrile, United States Patent US20120035387A1, Patent filed Feb 7, 2011, Invista North America S.a.r.l.
  18. Q3 2024 - Adiponitrile Production from Butadiene and HCN, Adiponitrile Operating Costs & Plant Construction Costs - INTRATEC
  19. Laura Bini et al. Ligand development in the Ni-catalyzed hydrocyanation of alkenes. Chemical Communications, vol. 46, no. 44, 2010, pp. 8325–8334. The Royal Society of Chemistry. DOI: 10.1039/C0CC01452D
  20. Dec 17, 2018 - INVISTA’s Orange, Texas, Site Sets Adiponitrile Production Record - Defence Industries
  21. Mar 26, 2021 - Invista Concludes Technology Upgrade at Victoria ADN Plant - Process Worldwide
  22. Nov 25, 2022 - INVISTA Celebrates Inauguration of 400,000-ton/year ADN Plant at the Shanghai Chemical Industry Park - INVISTA
  23. Oct 10, 2023 - INVISTA Closes Texas Facility, Amplifying Its Strategic Commitment to Shanghai - China Chemical Market Insights
Link
System Info

Updated by
UserPic  Kokel, Nicolas
Updated
7/9/2025 9:13 AM
Added by
UserPic  Kokel, Nicolas
Added
7/8/2025 2:56 PM
Solutions
Solutions

Solution-Reference:

#T346

No Services yet available.
Enquire in Solutions how we can help you.

Invista ADN Technolongy Block Flow Diagram based on patents US9040735B2, US10035756B2, EP1344770A1, and related INVISTA filings
Invista ADN Technolongy Block Flow Diagram based on patents US9040735B2, US10035756B2, EP1344770A1, and related INVISTA filings
Title Date
UserPic Invista ADN technology added 7/14/2025
Technology Unit